跳至主要内容
临床试验/NCT03149913
NCT03149913Unknown不适用

Does Local Paclitaxel Improve the Efficacy of Balloon Angioplasty Without Stent Implantation for Treatment of Below the Knee Artery Lesions?

Prof. Dr. med. Gunnar Tepe7 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2016年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
7
主要终点
Occlusion rate of the target lesion at 6 months

研究概览

简要总结

Patients with claudication or critical limb ischemia will be treated either with uncoated balloons or paclitaxel coated balloons in order to enhance the vessel patency in stenosed or occluded below the knee arteries

详细描述

After successful guide wire passage of the below the knee index lesions the patients will either receive a treatment with a conventional uncoated balloon or a balloon coated with paclitaxel. Only patients who require follow-up angiography after 6 months will be included in this study. The primary endpoint (index vessel occluded or still open) is at 6 months - the patients will be also followed for 24 months for clinical endpoints. In addition an MRI is planned at 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

drug coated balloon versus uncoated balloon

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •>18 years of age
  • •Chronic stenotic or occlusive atherosclerotic disease of the infrapopliteal arteries
  • •Rutherford 2-5 patients
  • •Patients with ≤ 2 BTK lesions (≥ 70% diameter stenosis)
  • •Lesion length limited to 5-25 cm

排除标准

  • •Planned or foreseeable amputation
  • •Previous amputation at the index limb
  • •Index vessel with no run-off to the foot distal to the index lesion
  • •Prior treatment of the index lesion with a drug coated balloon
  • •In-stent restenosis
  • •Life expectancy <1 year
  • •Known creatinine >1.4 mg% if patient is not on dialysis
  • •Acute thrombus in the index limb
  • •Aneurysm in the index leg
  • •Known hypersensitivity or contraindication to aspirin, heparin, clopidogrel, abciximab, paclitaxel
  • •Patients with concomitant medical illnesses that require cytostatic or radiation therapy

研究组 & 干预措施

Drug coated balloon

Experimental

SeQuentPlease OTW paclitaxel coated balloon catheter

干预措施: SequentPlease OTW paclitaxel coated balloon catheter (Device)

uncoated PTA balloon catheter

Active Comparator

Standard of care uncoated BTK balloon catheter

干预措施: conventional uncoated balloon for BTK endovascular therapy (Device)

结局指标

主要结局

Occlusion rate of the target lesion at 6 months

时间窗: 6 +/- 1 months

by digital substraction angiogram or MRI

次要结局

  • target lesion revascularization(3, 6, 12 and 24 months)

研究者

发起方
Prof. Dr. med. Gunnar Tepe
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Dr. med. Gunnar Tepe

Director of the Deparment of Radiology, Clinical Professor

Klinikum Rosenheim

研究点 (7)

Loading locations...

相似试验